Assessing Menopausal Status in Women Aged 40-49 Using Depot-Medroxyprogesterone Acetate, Norethisterone Enanthate Or Combined Oral Contraception (Original Articles) (Report)

Assessing Menopausal Status in Women Aged 40-49 Using Depot-Medroxyprogesterone Acetate, Norethisterone Enanthate Or Combined Oral Contraception (Original Articles) (Report)

Determining the onset of menopause in older users of hormonal injectable contraceptives depot medroxyprogesterone acetate (DMPA) and norethisterone enanthate (NET-EN) can be challenging. These contraceptive methods may mask menopausal symptoms such as amenorrhoea, which is a common side-effect of the method itself and increases in incidence over length of time used. (1) DMPA has been […]

South African Menopause Society Council Revised Consensus Position Statement on Menopausal Hormone Therapy (Statement)

South African Menopause Society Council Revised Consensus Position Statement on Menopausal Hormone Therapy (Statement)

The Council of the South African Menopause Society (SAMS) revised the 2004 statement (1) on menopausal hormone therapy (HT) at a consensus meeting held on 25/26 November 2006. The revision incorporated not only new evidence but also the re-evaluated evidence used in the previous statement. Clinicians are expected to practise in accordance with the findings […]